Litigation Details for Acadia Pharmaceuticals Inc. v. Aurobindo Pharma Ltd. (Fed. Cir. 2024)
✉ Email this page to a colleague
Acadia Pharmaceuticals Inc. v. Aurobindo Pharma Ltd. (Fed. Cir. 2024)
Docket | ⤷ Sign Up | Date Filed | 2024-01-29 |
Court | Court of Appeals for the Federal Circuit | Date Terminated | |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Patents | 7,601,740; 9,566,271 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Acadia Pharmaceuticals Inc. v. Aurobindo Pharma Ltd.
Details for Acadia Pharmaceuticals Inc. v. Aurobindo Pharma Ltd. (Fed. Cir. 2024)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-05-29 | 13 | ABBREVIATIONS ’740 patent U.S. Patent No. 7,601,740 (Appx79-108) ’271 patent …ASSERTED CLAIMS Asserted claim 26 of U.S. Patent No. 7,601,740 depends from claim 22: 22. A compound having… U.S. Patent No. 9,566,271 (Appx109-135) ’462 patent U.S. Patent No. 7,732,462 ’561 application… second patent on subject matter not patentably distinct from the claims of the first patent, … [a] patent… a later-filed patent that are not patentably distinct from the earlier[-]filed patent.” SimpleAir, Inc | External link to document | |
2024-03-29 | 9 | OTDP”) reference for U.S. Patent No. 7,601,740 (“the ’740 patent”) because it held that: 1. … Invalidity of U.S. Patent No. 7,601,740 For Double Patenting (D.I. 260) is …invalidity of claim 26 of U.S. Patent No. 7,601,740 ("the ' 740 patent") and have stipulated…Judgment of Invalidity of U.S. Patent No. 7,601,740 For Double Patenting (D.I. 260) is DENIED. …Invalidity of Claim 26 ofU .S. Patent No. 7,601 ,740 for Double Patenting and granting Acadia' | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |